Code | 1733E | ||||||||||
MA number | EU/1/19/1404/010 | ||||||||||
Product Form: | tbl plg 28x45 mg (blis.PVC/PE/PCTFE/Al) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | AbbVie Deutschland GmbH & Co. KG, Germany | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 16.12.2019 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | Rinvoq_Edukacna prirucka pre lekarov.pdf |
Dokument: | Rinvoq_Karta pacienta.pdf |
Safety feature | Yes |
Data update: | 10.10.2024 |